11111

11111

ABOUT EVENT

Welcome to the World Day of the Critical Lung

Dolor sit amet consectetur elit sed do eiusmod tempor incd idunt labore et dolore magna aliqua enim ad minim veniam quis nostrud exercitation ullamco laboris nisi ut aliquip exea commodo consequat.
  • Multiple Announcements during the event.
  • Logo & company details on the WordCamp.
  • Dedicated blog post thanking each Gold.
  • Acknowledgment and opening and closing.
OFFICIAL

Sponsors

Organizing Committee

Guillermo Ortiz

Guillermo Ortiz. MD, PhD

Colombia

manuel_jibaja

Manuel Jibaja. MD

Ecuador

Lluis-Blanch

Luis Blanch Torra. MD, PhD

España

Francesca Rubulotta

Francesca Rubulotta. MD, PhD

Italia

Maria Cruz Martin - ESPAÑA (2)

María Cruz Martín. MD

España

Pablo Cardinal-Fernández

Pablo Cardinal-Fernandez. MD, PhD

España

ErnestoBenalcazar3

Ernesto Benalcazar, MD

Panama

Dr. Julio Villanueva

J Villanueva, MD

España

PROGRAMME

Scientific Programme

The World Day of the Critical Lung.
VIII Edition
Time
Activity
Session 1:
Equality and gender
Session organized by the iWIN Foundation
13:00 - 13:05 Introduction. Martin-Delgado, M (Spain) & Vizcaychipi, V (UK)
13:05 - 13:20 Empowering women: mentoring and sponsoring Boissier, F (France)
13:20 - 13:35 Consider our unconscious bias. Hamzaoui (France)
13:35 - 13:50 Gender equity plan 2024. Saxena, S (Belgium)
13.50 - 14.00Women an unused reservoir of resources Rubulotta, F (Italy)
Welcome to the “VII The World Day of the Critical Lung“
14:15- 14:25 Guerrero, JE (Spain) in representation of HM Hospitales and Ortiz, G (Colombia) in representation of INSIMED. Martin-Delgado, M (Spain) ; Villanueva, J (Spain); Lorente, JA; (Spain) and Benalcazar, E.(Panama) in representation of organizing committee of the WDCL.
Session 2:
Respiratory insufficiency update
Session organized by the Sociedad Española de Medicina Intensiva y Unidades Coronarias (SEMICYUC)
14:45 - 14:50Introduction. Hernández, G (Spain)
14:50 - 15:05Update in the management of chronic respiratory patient. Marquez, M (Spain)
15:05 - 15:20Orotracheal intubation. Where are we? Gordo, F (Spain)
15:20 - 15:35Recent advances in extracorporeal membrane oxygenation. Riera, J (Spain)
15:35 - 15:50Questions & Answers
Session 3:
Acute respiratory distress syndrome
16:00 - 16:05Introduction. Blanch, L. (Spain)
16:05 - 16:20Sequential lateral positioning as a new lung recruitment maneuver. Roldan, R (Perú)
16:20 - 16:35When to intubate a patient with acute hypoxemic respiratory failure? Roca, O (Spain)
16:35 - 16:50What have we learnt from CIBERESUCI ARDSCOVID Cohort? Ceccato, A (Spain)
16:50 - 17:05Questions & Answers
Session 4:
Advances in the understanding of the pathophysiology acute lung injury:
A translational research perspective
17:15 - 17:20Introduction. Lorente, J.A. (Spain)
17:20 - 17:35Impact of tidal ventilation in lung repair. Amado, L (Spain)
17:35 - 17:50Is metoprolol useful in ARDS? Ioan, M (Spain)
17:50 - 18:05Clinical metabolomics for respiratory conditions. Izquierdo, JL (Spain)
18:05 - 18:20Questions & Answers
Session 5:
Bioethical issues in respiratory critical care patients.
18:30 - 18:35Introduction. Villanueva, J (Spain)
18:35 - 18:55A Bioethical Perspective for navigating moral dilemmas during COVID19 pandemic. Villanueva, J (Spain)
18:55 - 19:20What bioethics lessons have we learned from the recent COVID19 pandemic? Gomez, J (Spain)
19:20 - 19:35Questions & Answers
Session 6:
Controversies in mechanical ventilation
Session organized by the Pan American and Iberian Federation of Critical Medicine and Intensive Therapy (FEPIMCTI)
19:45 - 19:50Introduction. Benalcazar, E (Panama)
19:50 - 20:05Should Recruitment Maneuvers Be Used routinely or in special situations? Monares, E
20:05 - 20:20Update in ventilator induced lung injury. Fajardo-Campoverdi, A
20:20 - 20:35How to distinguish between self induced lung injury  (SILI) from drug induce lung injury (DILI). Saranguro, A
20:35 - 20:50Questions & Answers
Session 7:
Pneumonia update
21:45 - 21:50Introduction: Ortiz, G (Colombia)
21:50 - 22:05Steroids for community acquired pneumonia. Why, when, what dose, how long? Echeverry, J (Colombia)
22:05 - 22:20Molecular diagnosis for community acquired pneumonia . Molina, J (colombia)
22:20 - 22:35Prevention of hospital acquired pneumonia. González, M (Colombia)
22:35 - 22:50Questions & Answers
Session 8:
Clinical practice during advanced mechanical ventilation.
Session organized by the LIVEN (Latin American Intensive Care Network)
23:00 - 23:05Introduction: Jibaja, M. (Ecuador)
23:05 - 23:20Mechanical power. How to improve the ARDS clinical practice? Retamal, J (Chile)
23:20 - 23:35Driving Pressure: a risk factor or a clinical aim during mechanical ventilation? Bruhn, A (Chile)
23:35 - 23:50How to identify and classify patient-ventilator asynchronies. Murias, G (Argentina)
23:50 - 00:05Questions & Answers
Session 9:
Short and Long Term Outcomes of Oncology Patients in the ICU
Session organized by the Society of Critical Care Medicine (SCCM)
00:15 - 00:20 Introduction: Kinniry, J, ACNP, MSN (US)
00:20 - 00:35 Hematological and Oncological Emergencies in the ICU – Padmastuti, A (US)
00:35 - 00:50 Toxicities of ICIs and CAR-T Therapy in the ICU  - Pastores, S (US)
00:50 - 01:05 Evidence-Based Practices and Challenges in Oncological Critical Care - Kumar, S (US)
01:05 - 01:20 Questions & Answers
Closing lecture
01:20 - 01:35 Closing lecture – Perez, J (US)
President of the World Federation of Intensive care and Critical Care (United States)

11111

Eighth Edition

World Day of Critical Lung